Fact CheckerSign in

NCT07362108Completed

Cardiovascular Events Related to Treated Coronary Arteries in Stable Multivessel CAD

Cardiovascular Events Related to the Coronary Artery Treated by Surgical or Percutaneous Revascularization in Patients With Stable Multivessel Coronary Artery Disease: A Long-Term Comparison With Medical Therapy - Target Trial

Source: ClinicalTrials.gov · Last updated 23 Jan 2026

Brief summary (registry, in English)

This retrospective cohort study evaluates cardiovascular events directly related to treated coronary arteries in patients with stable multivessel coronary artery disease. Outcomes in patients undergoing coronary artery bypass grafting or percutaneous coronary intervention will be compared with those receiving optimized medical therapy alone. This study aims to improve understanding of how different treatment strategies impact long-term vessel-related outcomes in patients with stable multivessel coronary artery disease.

Status (registry)
Completed
Study type
Observational
Enrollment
1695 (actual)
First submitted
15 Jan 2026
Start date
1 Jan 1995
Primary completion date
31 Dec 2025
Lead sponsor
Instituto do Coracao
NCT number
NCT07362108

What you commit to

  • Study type: Observational
  • Participants enrolled: 1695
  • From 1 Jan 1995 to the primary completion date, 31 Dec 2025
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Lab values

  • Patients with limited life expectancy, severe left ventricular dysfunction (ejection fraction \<35%), recent acute coronary syndrome, recent revascularization procedures, significant valvular disease, chronic kidney disease (creatinine ≥2.0 mg/dL), active malignancy, or inability to complete long-term follow-up.

Who the study is looking for

  • Patients with stable multivessel coronary artery disease, defined as ≥70% stenosis in at least two major epicardial coronary arteries, with documented myocardial ischemia and clinical indication for surgical, percutaneous, or medical treatment.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.